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Extensive areas of aneuploidy are present in the respiratory epithelium of
lung cancer patients
AL Smith",2, J Hung', L Walker', TE Rogers23, F Vuitch2, E Lee2'3 and AF Gazdarl"2
'Simmons Cancer Center and 2Department ofPathology, University of Texas; Southwestern Medical Center and 3Veterans
Administration Medical Center, Dallas, Texas, USA.
Summary According to the field cancerisation theory the entire upper aerodigestive tract has been
mutagenised, thereby placing the affected individual at risk for the development of one or more cancers. To
investigate this concept we studied the respiratory epithelium in lungs bearing cancer, including bronchi,
bronchioles and alveoli. After identifying preneoplastic and preinvasive lesions by light microscopy, we
determined the DNA content of their nuclei in Feulgen-stained sections using a high-performance digitised
image analyser. Archival material from 35 resected cases of non-small-cell lung cancer (NSCLC) was selected,
including 16 central tumours (mainly squamous cell carcinomas) and 19 peripheral tumours (mainly adenocar-
cinomas) and five resected cases of metastatic tumour from extrathoracic primary sites. Of the NSCLCs, 31/35
(89%) were aneuploid, as were 60% of the metastases from extrathoracic sites. Multiple, focal areas of
preneoplasia or preinvasive carcinoma were present in the selected cases. The lesions ranged in severity from
hyperplasia through metaplasia and dysplasia to carcinoma in situ. Aneuploid preinvasive lesions were not
noted in association with the four diploid tumours but were present only when the accompanying NSCLC was
aneuploid. With both central and peripheral tumours, aneuploid preneoplastic lesions were more frequent in
the peripheral parts of the lung (bronchioles or alveoli) than in the central bronchi. Both the degree and
incidence of aneuploidy increased with progressive severity of morphological change. Aneuploidy was not
found in preinvasive lesions accompanying the five metastatic cases. Our findings provide strong support for
the concept of field cancerisation.
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Lung cancer, including small-cell (SCLC) and non-small-cell
(NSCLC) lung carcinoma, remains the major cause of cancer
death in the world, with a persistent mortality rate app-
roaching 90% (Minna et al., 1989; Parkin et al., 1993).
Current methods for early detection have failed to prolong
the median survival time of some 12 months (Anon, 1984;
Kubik et al., 1990). Thus there is a pressing need for im-
proved ways to detect lung cancer early and to assess patient
risk. The rapidly emerging capabilities of molecular tech-
nology seem especially appropriate in targeting those cellular
changes that presage the evolution of neoplasia before the
development of invasive cancer. Such studies may provide
methods for prevention or modification of the neoplastic
process (Lippman et al., 1993).
Three important concepts dominate our current beliefs
about the pathogenesis of lung cancer:
(1) Multiple sequential morphological changes characterise
lung cancers. To identify groups of phenotypically altered
cells in various body tissues possibly targeted by car-
cinogen, the term preneoplasia is used. By definition,
preneoplasia, although believed to possess carcinogenic
potential, is not fixed in its destiny to become cancerous.
Nevertheless, changes of preneoplasia have been shown to
reflect consistently sequential steps in carcinogenesis, and
the respiratory epithelium provides an excellent model in
which to study such a process. Tumours of the respiratory
epithelium may arise in the central compartment (from
bronchi) or in the peripheral compartment (from bron-
chioles or alveoli). Because of ease of accessibility, the
best-documented examples of preneoplastic and pre-
invasive lesions are in the larger bronchi associated with
central tumours. They include epithelial hyperplasia,
squamous metaplasia, dysplasia of progressive severity
and carcinoma in situ (CIS) (Saccomanno et al., 1974;
Auerbach et al., 1979). Similar but less well documented
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changes may appear in non-metaplastic epithelium of
bronchioles and alveoli in association with peripherally
arising carcinomas (Nakanishi, 1990; Weng et al., 1990;
Shimosato -et al., 1993). However, most preneoplastic
lesions do not progress to invasive cancer and some may
spontaneously regress (Auerbach et al., 1962a; Frost et
al., 1986).
(2) Multiple genetic abnormalities including activation or
overexpression of dominantly acting oncogenes and inac-
tivation of recessive growth-regulatory genes (tumour-
suppressor genes) are associated with most tumours
(Minna, 1993; Gazdar and Carbone, 1994). Presently
there is only a modest amount of knowledge about the
sequence of molecular events in lung and their relation-
ship to morphology (Sundaresan et al., 1992; Sugio et al.,
1994; Hung et al., 1995).
(3) The 'field cancerisation' theory states that the epithelium
of the upper aerodigestive tract has been mutagenised,
presumably as a result of exposure to carcinogens such as
in tobacco smoke, and therefore is at increased risk for
the development of one or more cancers. In 1953, Slaugh-
ter reported his clinical observations of multiple epithelial
tumours arising in the upper aerodigestive tract (Slaugh-
ter et al., 1954). He referred to this phenomenon as 'field
cancerisation,' a concept that has since been extended by
others (Heyne et al., 1992; Sagman et al., 1992). While
Slaughter's observations were originally directed to head
and neck cancers, they apply equally well to tumours of
the respiratory tract and oesophagus (Carter, 1978; Sacc-
omanno, 1982; McCombe et al., 1989; Heyne et al., 1992;
Sagman et al., 1992).
Further evidence of widespread genetic damage and DNA
instability is evidenced by the frequent presence of aneu-
ploidy (that is, abnormal nuclear content of DNA) in
invasive lung cancers of all histological types (Bunn et al.,
1983; Volm et al., 1988). Aneuploidy may be determined by
several techniques such as quantitative flow cytometry,
cytospectrophotometry and image analysis (Boone et al.,
1992). Because precise histological identification is essential
for the studies described herein, we used a high-performanceAneuploidy in lung preneoplasia r0 AL Smith et al
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image analyser to map the extent and degree ofaneuploidy in
preneoplastic lesions in both compattments of the respiratory
epithelium. Our studies demonstrate that multiple foci of
aneuploidy occur at a relatively early stage in the patho-
genesis of both central and peripheral tumours and lend
credence to the field cancerisation concept.
Materials and methods
Patient selection and data
Specimens of cancerous lung were obtained from the surgical
pathology files of the Department of Pathology, University
of Texas Southwestern Medical Center and affiliated hos-
pitals. They had been fixed in 10% buffered formalin and
embedded in paraffin. After examination of more than 100
cases we selected 40 cases representing patients in whom
surgical resection had been done for cancer and in whose
specimen multiple areas of preneoplasia were present. Thirty-
five patients, ranging in age from 41 to 81 years, had primary
lung cancers; five had metastases from extrathoracic primary
sites. Twenty-three cancers were from the right lung and 17
from the left. Lobectomy was performed in 27 patients,
pneumonectomy in four and wedge resection or lingulectomy
in nine.
a
b
Figure I Peripheral airway changes associated with peripherally
arising adenocarcinoma. (a) Adenomatous hyperplasia of type II
pneumocytes. The air space is lined by a continuous layer of
hyperplastic type II cells, some of which show minimal dysplastic
changes. The widespread, multifocal nature of the changes distin-
guishes them from alveolar adenomas (see Figure 2a). (b) Spread
of peripheral adenocarcinoma along a bronchiolar wall. Tumour
cells (T) abut onto histologically normal epithelium (E). The
basement membrane is intact. Intraepithelial tumour spread of
this type cannot be distinguished from carcinoma in situ.
Pathological examination
We categorised the 35 primary NSCLCs into two groups: (a)
those connected to and apparently arising from a bronchus
as central tumours (n = 16) (mostly squamous cell car-
cinomas) and (b) those not connected to a bronchus and
apparently arising from bronchioles or alveoli as peripheral
tumours (n = 19) (mostly adenocarcinomas). We included
four other malignancies, an atypical carcinoid (central
tumour), two large cell carcinomas and an adenosquamous
carcinoma (peripheral tumours). The five metastatic neo-
plasms were renal, laryngeal, breast (one each) and two
colorectal carcinomas.
To locate and identify preneoplastic lesions in central and
peripheral components of the respiratory tract we examined
all available histological material from all cases. After
pathological examination we selected suitable tissue blocks
(1-3 per case) for further analysis. Tissue blocks were
serially sectioned at 5,um to give matched pairs of micro-
slides, one of which was stained with haematoxylin and eosin
(H&E) and the other by the Feulgen reaction (Feulgen and
Voit, 1924). By identifying lesions in each pair ofmicroslides,
we correlated conventional morphology with ploidy.
Identification ofpreneoplastic lesions
Bronchial, bronchiolar and alveolar lining surfaces of the
respiratory tract were inspected by brightfield microscopy for
the presence and range in severity of the key lesions of
preneoplasia - hyperplasia, metaplasia and dysplasia. We
included non-invasive carcinoma or carcinoma in situ (CIS)
as a preneoplastic lesion although technically it is a pre-
invasive one. Our criteria for identification of preneoplastic
lesions in the different compartments of the respiratory tract
were as follows (some of the lesions are illustrated in Figures
1 and 2):
Hyperplasia in bronchi is an increase in number of otherwise
normally appearing cells normally arranged but in over-
crowded multilayered displays of basal or mucous cells. The
single cell lining of bronchioles is replaced by basal or Clara
cells crowded and piled upon one another. In pulmonary
alveoli, hyperplastic type II pneumocytes appear enlarged
and occasionally piled up. They may be multinucleated with
delicately vacuolated cytoplasm and show small, round
nucleoli.
Metaplasia is replacement of the usual respiratory epithelium
by squamous epithelium showing a relatively normal matura-
tion process. It is present mainly in bronchi, occasionally in
bronchioles.
Dysplasia is the distortion of normal cytological features,
usually with disturbed polarity. It is characterised by the
presence of enlarged, hyperchromatic and irregularly shaped
nuclei. The nuclear cytoplasmic (N/C) ratio in dysplastic cells
is consistently increased. While dysplasia in respiratory
epithelial cells is often associated with squamous metaplasia,
dysplastic changes may be seen in the non-metaplastic res-
piratory epithelium. In our study the findings of adeno-
matous hyperplasia/alveolar adenoma, which may be ob-
served in peripheral airspaces, are included in the lesions
evaluated as 'dysplasia'.
Alveolar adenoma and adenomatous hyperplasia are related
entities (Figures la and 2a-d), in which the component cells
arise from type II alveolar pneumocytes, which may however
acquire features of Clara cells. Because the concept of
alveolar adenoma is recent (Miller et al., 1988; Miller, 1990;
Shimosato et al., 1993; Shimosato and Miller, 1993), we
describe its features. While it has also been termed
bronchioloalveolar adenoma (Miller, 1990), we use the term
alveolar adenoma for this entity. In adenomas, the alveolar
lining is replaced by a single layer ofcuboidal cells with scant
cytoplasm. A mild to moderate degree of nuclear atypism isAneuploidy in lung preneoplasia
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Figure 2 Alveolar adenomas. (a) A small alveolar adenoma (A) lies adjacent to but separate from pulmonary metastases (T)
arising from a colon carcinoma. Low power (b) and high power (c) photomicrographs of an alveolar adenoma adjacent to a
peripheral adenocarcinoma (d). In the adenoma, the fibrous septae are relatively narrow, adjacent cells frequently are separated,
cytoplasm is scant and only mild nuclear atypia is present. In the adenocarcinoma the septae are broader, the cells form a
continuous layer, cytoplasm is relatively abundant and the degree of nuclear atypism is greater.
frequent, although the atypical changes are not severe
enough to confuse the lesion with well-differentiated non-
mucinous papillary adenocarcinoma. A mild degree of inter-
stitial fibrosis is present frequently. Mucin is absent and
mitoses are relatively rare. When such changes occur as
several diffuse foci without distinct borders they are referred
to as atypical adenomatous hyperplasias, whereas single or
multiple well-defined discrete foci have been called alveolar
adenomas.
Carcinoma in situ (CIS) is identified when cells with all the
nuclear and cytoplasmic features of malignancy are present
but limited to a given surface by an intact basement mem-
brane. CIS may occur in the bronchi, as the preinvasive form
of squamous cell carcinomas, or in the peripheral compart-
ments (bronchioles and alveoli) as the preinvasive form of
adenocarcinomas. Because peripheral adenocarcinomas fre-
quently demonstrate growth along pre-existing alveolar and
bronchiolar surfaces ('lepidic growth') (Greenberg, 1987), the
distinction between the lepidic tumour growth of adeno-
carcinoma or adenocarcinoma in situ is obscure (Figure lb).
We use the term CIS for this growth pattern without further
qualification.
Ploidy analysis
The Feulgen reaction, a two-step procedure specific for DNA
(Feulgen and Voit, 1924), was performed as previously des-
cribed (Carson, 1990). The Feulgen reaction allows the
stoichiometric measurement of DNA (Nasiell and Kato,
1978). Quantitative image analysis was performed using the
Microlmager System Model no. 1400 developed by Xillix
Technologies Corporation, Richmond, British Columbia,
Canada (Palcic et al., 1990; Jaggi et al., 1991). Briefly, the
Microlmager 1400 consists of a 1320 x 1035 pixel scientific
charge-coupled device (CCD) positioned in the primary
image plane of a flat field objective lens free of chromatic
aberration (Nikon, Fluor 20 1.60/017). The CCD has a
6.8 x 6.8tim pixel size, 100% fill factor and a dynamic range
of 60 dB. The output signal is amplified and digitised to 10
bits as it is read off the CCD, yielding digital images that can
be resolved at about 0.28gim in brightfield microscopy mode
on the Microlmager 1400. The digitised image is transferred
to an interface imaging board that resides in a 80486 based
host computer from which it can be displayed on an RGB
(red, green, blue) monitor and processed (Palcic et al., 1990;
Jaggi et al., 1991).
To reduce the effects of uneven field illumination, glare
and fixed pattern noise, calibration by background correction
was performed for each microslide. An empty microscopic
field was digitised 15 times and the average image stored in
computer memory to be subtracted from each measured field.
Quantitative microscopy was performed using Kohler ill-
umination. The illumination was restricted to 550 nm with a
70 nm bandwidth since this corresponds to the spectral max-
imum absorption of the Feulgen stain. After identification of
preneoplastic lesions in the H&E-stained microslide, corres-
ponding areas were localised in the matched Feulgen-stained
microslide. Since the Feulgen stain is stoichiometric for
DNA, the total nuclear absorbance or integrated optical
density (IOD) is proportional to the DNA content of the
nucleus. Between 100 and 200 discrete, carefully selectedAneuploidy in lung preneoplasia
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nuclei from lymphocytes and representative cells for each
diagnostic category were segmented by greyscale thresholding
and analysed. Because of interslide staining variations, the
IOD must be normalised to obtain the DNA index (DI). For
each microslide analysed the average IOD of around 100
normal diploid stromal lymphocytes from the test section
were used to normalise the modal IOD peaks of the various
epithelial cell types evaluated.
After the lesions of concern had been identified in routine
H&E sections, the corresponding areas in the Feulgen-stained
sections were subjected to image analysis. Measurements of
the diploid lymphocytes (100-200 collected per slide) in the
paraffin sections of these cases demonstrated that the
coefficient of variation of the IOD, a measure of the DI, was
11% for the lymphocytes. The coefficient of variation of the
IOD for proliferating epithelial cells was determined to be
less than 18%. Based on those observations we designated
aneuploidy when the nuclear DI was greater than 1.2. When
the DI values were 1.2 or less the cells were regarded as
diploid.
Statistical tests
Statistical comparisons between proportions were made using
the chi-square statistic. For comparisons with small cell sizes,
expected value less than 5, a Fisher's exact test was applied
since the chi-square test is a poor approximation of the
Table I Incidence and location of preneoplastic lesions
Location ofpreneoplastic lesions
Tumour location Bronchi Bronchioles/alveoli
NSCLC, all (n = 35) 22/35 (63%) 35/35 (100%)
(18 adenomasa)
Central (n = 16) 12/16 (75%) 16/16 (100%)
(9 adenomas)
Peripheral (n = 19) 10/19 (53%) 19/19 (100%)
(9 adenomas)
Metastases (n = 5) 2/5 (40%) 5/5 (100%)
(2 adenomas)
'All alveolar adenomas.
significance. Statistical significance was taken as P-values less
than 0.05.
Results
Incidence and location ofpreneoplastic lesions
After examination of over 100 resections for primary lung
carcinomas, 35 cases having associated preneoplastic lesions
at multiple sites were selected. Also, five pulmonary resec-
tions (of eight examined) for metastatic carcinoma having
similar changes (although usually milder) were selected. As
seen in Table I, in both central and peripheral tumours a
higher frequency of lesions was present in the peripheral
compartment of the lung (that is, bronchioles and alveoli)
than in the central one (that is, bronchi). Alveolar adenomas
were identified in 20/40 cases (in 18/35 resections for primary
lung cancer and two out of five resections for metastatic
cancers).
Incidence and degree ofaneuploidy in tumours and
preneoplastic lesions
As demonstrated in Table II 31/35 (89%) of primary lung
cancers (mean DI value 1.8, range 1.3-2.9) and three out of
five (60%) of metastatic carcinomas were aneuploid. The
incidences of aneuploidy in squamous cell carcinomas (93%)
and adenocarcinomas (81%) were not judged to be statis-
tically different (P = 0.600, Fisher's exact test). The incid-
ences of aneuploidy in preneoplastic lesions associated with
the central (57%) and peripheral (62%) tumours were also
not judged significantly different (P = 0.816, chi-square test).
Aneuploidy in corresponding preneoplastic lesions was
present in 18/31 (58%) of the aneuploid NSCLCs (Table III).
Aneuploidy was absent in preneoplastic lesions associated
with near-diploid tumours and with metastatic tumours.
Thus only aneuploid tumours displayed aneuploidy in
preneoplasia. An example of a typical DNA histogram is
illustrated in Figure 3.
As also shown in Table III, aneuploid preneoplastic lesions
were present throughout the central and peripheral compart-
Table II Frequency of aneuploidy in preneoplastic lesions
Number aneuploid/number tested (per cent)
No. aneuploidl Aneuploidy in one or more preneoplastic lesions
no. oftumours Aneuploid
Tumour type (%) All tumours (%) Diploid tumours tumours (%)
Lung, all 31/35 (89) 18/35 (51) 0/4 18/31 (58)
Squamous 14/15 (93) 8/15 (53) 0/1 8/14 (57)
Adenocarcinoma 13/16 (81) 8/16 (50) 0/3 8/13 (62)
Other 4/4 (100) 2/4 (50) - 2/4 (50)
Metastases 3/5 (60) 0/5 (0) 0/2 0/3 (0)
Forty tumours were examined, including 35 primary lung carcinomas and five pulmonary
metastases from extrathoracic primary carcinomas.
Table III Location of aneuploid preneoplastic lesions
Location ofaneuploidy in preneoplastic lesions
Tumour location Any site (%) Bronchi (%) Bronchioles/alveoli (%)
NSCLC, all (n = 31) 18 (58) 5 (16) 16 (52)
(3/18 adenomasa)
Central (n = 15) 9 (60) 2 (13) 8 (53)
(1/9 adenomas)
Peripheral (n = 16) 9 (56) 3 (19) 8 (50)
(2/9 adenomas)
Metastases (n = 3) 0 0 0
(0/2 adenomas)
Because aneuploid preneoplastic lesions were not found in diploid tumours, the data
presented are limited to the aneuploid tumour subsets. The aneuploid central NSCLCs
included 14 squamous cell and oneatypical carcinoid. Theaneuploid peripheral NSCLCs
included 13 adenocarcinomas, two large cell carcinomas and one adenosquamous
carcinoma. aAneuploidy was found in three alveolar adenomas, one associated with a
central tumour and two with peripheral tumours.
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Figure 3 Representative DNA histogram demonstrating aneu-
ploidy in a peripheral adenocarcinoma and in associated dysplas-
tic alveolar type II cells. Several adenocarcinomas, including the
one illustrated, demonstrated a broad, multipeak pattern. The
associated dysplastic type II pneumocytes, several microscopic
fields distant from the invasive carcinoma, have two aneuploid
peaks. LIII, Lymphocytes; ED , tumour cells; -, type II cells.
ments of the lung. However, the concentration of such
lesions was greater in the periphery of the specimens, that is,
in bronchioles and alveoli. The incidence and distribution for
central and peripheral tumours were similar; the percentages
for either compartment as well as for all tumours were
approximately the same. Aneuploidy in bronchioles and pul-
monary alveoli (peripheral compartment) was found in 53%
of central tumours whereas in peripheral tumours, only 19%
of the preneoplastic lesions were in bronchi (central compart-
ment). From Tables I and III, it is apparent that the lesions
of preneoplasia were concentrated in the peripheral compart-
ment with no correlation with the anatomic site of origin of
tumour.
Incidence and degree ofaneuploidy correlated with tissue lesion
As demonstrated in Figure 4 the incidence and degree of
aneuploidy increased in correlation with progressive severity
of morphological change. In all aneuploid cases the DI
values of the tumours were higher than those of their corres-
ponding preneoplastic lesions. Aneuploidy was not found in
histologically normal epithelium. A low level of aneuploidy
was found in a minority of hyperplastic lesions, but the
distinction between hyperplasia and mild dysplasia in
Feulgen-stained microslides is difficult. Of 18 alveolar
adenomas found in association with primary lung car-
cinomas, three (17%) were aneuploid (mean DI of 1.4). Two
adenomas associated with metastatic cancers were diploid.
Discussion
Understanding the molecular changes in the respiratory
epithelium that precede the development of invasive cancers
is crucial to the development of rational strategies for
therapy and chemoprevention. Therefore, elucidation of the
meaning of field cancerisation and its implications represents
an important area in carcinogenesis research (Lippman et al.,
1993). In an effort to evaluate the relationship between
preneoplastic changes and invasive carcinoma we determined
the ploidy of the various preneoplastic changes found
throughout the respiratory epithelium of patients with lung
cancers.
Multifocal histopathological lesions are present in the res-
piratory epithelium of patients with lung cancer. A link has
been established between smoking and radiation and the
appearance and sequential progression of bronchial (central)
preneoplastic lesions to invasive lung cancers (Auerbach et
al., 1957, 1962b; Saccomanno et al., 1974). Histologically
similar changes have been described even in the lungs of
patients without cancer or in association with metastases to
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Figure 4 Incidence and degree of aneuploidy in NSCLC and
corresponding preneoplastic lesions. Dysplasia as previously
indicated incorporates DI values for three aneuploid alveolar
adenomas. (a) The percentage of lesions with aneuploidy. (b)
Their respective mean DNA indices.
the lung from non-pulmonary primary cancers (Bernardi and
Delsedime, 1989; Nakayama et al., 1990; Weng et al., 1992;
Shimosato et al., 1993). That moderate to severe squamous
bronchial (central) dysplasia may spontaneously regress or
never progress to invasive carcinoma has also been reported
(Auerbach et al., 1962a; Frost et al., 1986).
Much less is understood about the relationship between
the dysplastic changes of adenomatous hyperpl,asias in the
peripheral parts of the lung and adenocarcinomas or other
lung cancers. However, such lesions in peripheral lung are
more common with adenocarcinomas (Weng et al., 1990),
suggesting they are indeed precancerous. Peripheral aden-
omas are alveolar lesions that are frequently found in
association with adenocarcinomas and occasionally with
other forms of NSCLC (Weng et al., 1992). They have been
postulated to be an intermediate step in the development of
peripheral adenocarcinomas (Miller, 1990; Shimosato et al.,
1993). Since the malignant potential for many of these histo-
pathological changes is not fully understood, for con-
venience, we refer to all of them as being preneoplastic.
We compared the frequency and degree of aneuploidy in
preneoplastic lesions with their corresponding carcinomas.
We found that 31 (89%) of 35 of the primary tumours were
aneuploid with a mean DNA index (DI) of 1.8. This finding
is in accord with previously published reports (Bunn et al.,
1983; Volm et al., 1988). We observed aneuploidy in one or
more preneoplastic lesions in 18 (51%) of 35 cases. However,
aneuploidy was only present when the accompanying car-
cinoma was aneuploid (58% of the aneuploid tumour
subset). Although some preneoplastic lesions had a DI
greater than 1.5, in every instance, the DI of the tumour was
greater than in the corresponding preneoplastic lesion. Three
(60%) of five metastatic tumours were aneuploid, but none
of the relatively mild preneoplastic lesions associated with
metastatic tumours was aneuploid.
The degree and incidence of aneuploidy increased with
progressive severity of histopathological change. Aneuploidy
was occasionally observed in hyperplasia, usually appeared at
the stage ofdysplasia and then escalated along the postulated
multistage pathway into invasive cancer. Although a low
level of aneuploidy was detected in 20% of hyperplastic
lesions, a distinction between hyperplasia and mild dysplasia
in Feulgen-stained microslides is difficult. We believe that
aneuploidy appears at the hyperplasia-dysplasia interface.
Our findings indicate that dysplastic lesions throughout the
respiratory tree frequently demonstrate aneuploidy. Multiple
lesions in bronchi (central compartment) and in bronchioles
and alveoli (peripheral compartment) demonstrated aneu-
ploidy. Of note, aneuploidy was found in central and
peripheral lung compartments associated with both centrally
and peripherally arising lung carcinomas. Thus the location
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of aneuploid lesions does not necessarily correlate with the
presumed compartment of tumour origin. The presence of
aneuploidy in peripheral foci is of interest because the
natural history of these lesions is unknown. While aneu-
ploidy in pulmonary preneoplasia has been reported by
others (Nakayama et al., 1990; Kogan et al., 1991; Shimosato
et al., 1993). our report documents that it is extensive,
especially in the peripheral parts of the lung. These findings
provide support for the concept that the peripheral lesions
are truly preneoplastic in nature.
Because aneuploidy can predispose to genomic instability
(Loeb, 1991), it may be one of the predisposing causes of the
multiple genetic abnormalities frequently present in invasive
cancers. Reports of cytogenetic and other changes in
preneoplastic bronchial lesions and even in 'normal' bron-
chial epithelium provide further evidence for this concept
(Sozzi et al., 1991. 1992). Recently, we have described dele-
tions of the short arm of chromosomes 3 and 9 in hyperplas-
tic lesions throughout the respiratory tree (Hung et al., 1995).
These chromosomal regions are the sites of known or
putative recessive oncogenes important for the development
of lung cancers of all histological types (Minna, 1993; Gaz-
dar and Carbone. 1994). Thus aneuploidy may contribute to
the multiple other genetic changes occurring in preneoplastic
lesions long before the deveolopment of invasive cancer. Of
interest, 3120 (15%) of all alveolar adenomas examined were
aneuploid. These data help validate the concept that many
peripheral carcinomas may arise from alveolar adenomas,
similar to the adenoma-carcinoma sequence present in colon
cancer (Miller, 1990; Shimosato et al., 1993).
Aneuploidy is present in multiple preneoplastic foci located
throughout the respiratory epithelium from the stage of dys-
plasia onwards and increases in incidence and degree with
progressive histopathological changes. These findings provide
considerable support for the field cancerisation theory. Thus,
aneuploidy may be a useful intermediate marker for assessing
risk and monitoring the efficacy of chemoprevention trials.
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